THM Capital Advisory advises ADVANCED LIFE SOLUTIONS for the fundraising of the second tranche of its Series A

2024

THM Capital Advisory accompagne la société Advanced Life Solutions pour lever la seconde tranche de sa Série A. Advanced Life Solutions est une medtech qui développe un liquide innovant de préservation des organes transplantés.

Created by Silvina Ramella, an internationally renowned scientist in organ transplantation and former CEO at one of the leading European companies in the industry, Advanced Life Solutions has developed Perla®, a new liquid for preserving and protecting grafts, which aims to improve the functional recovery of transplanted organs and their lifespan.

Perla® helps to protect more fragile grafts that come from older donors. Liquids currently available in transplant services have existed for 30 to 40 years and are becoming less and less suitable for this new type of more “sensitive” organ, which is also the most readily available today.

After a first tranche in 2022, ALS raised the second tranche of €2.5m of its Series A to fund its development in Europe, the USA and the Middle East. The two previous family offices which invested in 2022 led the tour.

 

FOUNDERS ADVISORS: Financial: THM Capital Advisory (Thomas Mitard, Aurélien Prost); Legal: McDermott Will & Emery (Henri Pieyre de Mandiargues)

Medtech/Biotech

logoLevée de fonds

2024